Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 02:13:02 - browse：62

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： 'The Exorcist' director William Friedkin dead at 87

WSS

The best solution to the drug shortages problem

Emergent cuts jobs, executive role in business shake

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Wegovy’s successful heart trial raises vital question about weight loss

Mississippi candidates for statewide offices square off in party primaries

In medicine, common shorthands can shortchange care

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Supreme Court strikes down use of affirmative action

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Virginia high school admissions case could be legal follow

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Apple is now the first public company to be valued at $3 trillion

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Drug repurposing or repositioning? The language matters

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Medicare details structure of new drug price negotiation program

Methadone doses haven’t kept up in the age of fentanyl

hotspot

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Wegovy trial has doctors encouraged over new possibilities

Naloxone nonprofit donates 200,000 doses after FDA approval

Biden will tout long

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

hotspot

explore

Wikipedia

entertainment